Cellectar Biosciences, Inc. Banner Image

Cellectar Biosciences, Inc.

  • Ticker CLRB
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Cellectar Biosciences, Inc. Logo Image
  • 1-10 Employees
  • Based in Florham Park, New Jersey
Cellectar Biosciences is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company is developing proprietary drugs independently and through research and development collaborations. The company’s core objective is to leverage its proprietary Phospholipid Drug Conjugate™ (PDC) delivery platform to develop PDCs that specifically target cancerMore cells, delivering improved efficacy and better safety as a result of fewer off-target effects. The company’s PDC platform possesses the potential for the discovery and development of the next-generation of cancer-targeting treatments, and it plans to develop PDCs independently and through research and development collaborations.
Cellectar Biosciences, Inc.

Most Recent Annual Report

Cellectar Biosciences, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports